Clinical Trial Update: Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide in combination with chemotherapy for peripheral T-cell lymphoma. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Ruijin Hospital | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: UNKNOWN